6 Controversial aspects of cytoreductive surgery in epithelial ovarian cancer
- 1 March 1989
- journal article
- review article
- Published by Elsevier in Bailliere's Clinical Obstetrics and Gynaecology
- Vol. 3 (1) , 49-57
- https://doi.org/10.1016/s0950-3552(89)80041-0
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Prognostic implications of large volume residual disease in patients with advanced stage epithelial ovarian cancerGynecologic Oncology, 1987
- Cytoreductive Surgery in Ovarian CarcinomaObstetrics & Gynecology, 1986
- Chemotherapy of advanced ovarian adenocarcinoma: A randomized comparison of combination versus sequential therapy using chlorambucil and cisplatinGynecologic Oncology, 1986
- Assessment of morbidity and mortality in primary cytoreductive surgery for advanced ovarian carcinomaGynecologic Oncology, 1985
- The james ewing lecture. The relationship between tumor mass and resistance to chemotherapy. Implications for surgical adjuvant treatment of cancerCancer, 1983
- Debulking surgery: Does it increase the quality of survival?Gynecologic Oncology, 1982
- Immunodiagnosis in ovarian cancer: Blocking factor activityAmerican Journal of Obstetrics and Gynecology, 1979
- Changing concepts of cancer surgery: Surgery as immunotherapyThe American Journal of Surgery, 1978
- Cell‐mediated Immunity: Effect of Female Genital Tract Cancer, Pregnancy and Immunosuppressive DrugsAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1975
- The changing prognosis and treatment in cancer of the ovaryAmerican Journal of Obstetrics and Gynecology, 1968